These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 27547842)

  • 1. The size and behavior of the human upper airway during inhalation of aerosols.
    Nikander K; von Hollen D; Larhrib H
    Expert Opin Drug Deliv; 2017 May; 14(5):621-630. PubMed ID: 27547842
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dynamic change of the upper airway during inhalation via aerosol delivery devices.
    Ehtezazi T; Horsfield MA; Barry PW; O'Callaghan C
    J Aerosol Med; 2004; 17(4):325-34. PubMed ID: 15684732
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of the Respimat Soft Mist Inhaler using a concurrent CFD and in vitro approach.
    Worth Longest P; Hindle M
    J Aerosol Med Pulm Drug Deliv; 2009 Jun; 22(2):99-112. PubMed ID: 18956950
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of Pressurized Metered Dose Inhaler Spray Characteristics and Particle Size Distribution on Drug Delivery Efficiency.
    Yousefi M; Inthavong K; Tu J
    J Aerosol Med Pulm Drug Deliv; 2017 Oct; 30(5):359-372. PubMed ID: 28463041
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Does upper airway deformation affect drug deposition?
    Cheng S; Kourmatzis A; Mekonnen T; Gholizadeh H; Raco J; Chen L; Tang P; Chan HK
    Int J Pharm; 2019 Dec; 572():118773. PubMed ID: 31678391
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Computationally efficient analysis of particle transport and deposition in a human whole-lung-airway model. Part II: Dry powder inhaler application.
    Kolanjiyil AV; Kleinstreuer C; Sadikot RT
    Comput Biol Med; 2017 May; 84():247-253. PubMed ID: 27836120
    [TBL] [Abstract][Full Text] [Related]  

  • 7. An increase in laryngeal aerosol deposition by ultrasonic nebulizer therapy with intermittent vocalization.
    Kumazawa H; Asako M; Yamashita T; Ha-Kawa SK
    Laryngoscope; 1997 May; 107(5):671-4. PubMed ID: 9149172
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Experimental measurements of particle deposition in three proximal lung bifurcation models with an idealized mouth-throat.
    Zhang Y; Finlay WH
    J Aerosol Med; 2005; 18(4):460-73. PubMed ID: 16379621
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparative performance of two inhaler systems to assess distribution of convective ventilation by 99mTc-labeled aerosol scintigraphy in patients with airway obstruction.
    Fazzi P; Borsò E; Albertelli R; Mariani G; Giuntini C
    Q J Nucl Med Mol Imaging; 2009 Aug; 53(4):428-36. PubMed ID: 19174757
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Added external resistance reduces oropharyngeal deposition and increases lung deposition of aerosol particles in asthmatics.
    Svartengren K; Lindestad P; Svartengren M; Philipson K; Bylin G; Camner P
    Am J Respir Crit Care Med; 1995 Jul; 152(1):32-7. PubMed ID: 7599841
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Deposition of inhaled particles in the mouth and throat of asthmatic subjects.
    Svartengren K; Lindestad PA; Svartengren M; Bylin G; Philipson K; Camner P
    Eur Respir J; 1994 Aug; 7(8):1467-73. PubMed ID: 7957832
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of patient inhalation profile and airway structure on drug deposition in image-based models with particle-particle interactions.
    Williams J; Kolehmainen J; Cunningham S; Ozel A; Wolfram U
    Int J Pharm; 2022 Jan; 612():121321. PubMed ID: 34875355
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Sophia Anatomical Infant Nose-Throat (Saint) model: a valuable tool to study aerosol deposition in infants.
    Janssens HM; de Jongste JC; Fokkens WJ; Robben SG; Wouters K; Tiddens HA
    J Aerosol Med; 2001; 14(4):433-41. PubMed ID: 11791684
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Performance Comparisons of Jet and Mesh Nebulizers Using Different Interfaces in Simulated Spontaneously Breathing Adults and Children.
    Ari A; de Andrade AD; Sheard M; AlHamad B; Fink JB
    J Aerosol Med Pulm Drug Deliv; 2015 Aug; 28(4):281-9. PubMed ID: 25493535
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lung deposition of 99mTc-radiolabeled albuterol delivered through a pressurized metered dose inhaler and spacer with facemask or mouthpiece in children with asthma.
    Ditcham W; Murdzoska J; Zhang G; Roller C; von Hollen D; Nikander K; Devadason SG
    J Aerosol Med Pulm Drug Deliv; 2014 Aug; 27 Suppl 1():S63-75. PubMed ID: 25054483
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A dry powder inhaler with reduced mouth-throat deposition.
    Wang ZL; Grgic B; Finlay WH
    J Aerosol Med; 2006; 19(2):168-74. PubMed ID: 16796541
    [TBL] [Abstract][Full Text] [Related]  

  • 17. An experimental method for measuring aerosol deposition efficiency in the human oral airway.
    Cheng KH; Cheng YS; Yeh HC; Swift DL
    Am Ind Hyg Assoc J; 1997 Mar; 58(3):207-13. PubMed ID: 9075311
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inspiratory and expiratory aerosol deposition in the upper airway.
    Verbanck S; Kalsi HS; Biddiscombe MF; Agnihotri V; Belkassem B; Lacor C; Usmani OS
    Inhal Toxicol; 2011 Feb; 23(2):104-11. PubMed ID: 21309663
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Deposition of Particles in Human Mouth-Throat Replicas and a USP Induction Port.
    Cheng YS; Zhou Y; Su WC
    J Aerosol Med Pulm Drug Deliv; 2015 Jun; 28(3):147-55. PubMed ID: 25137223
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Empirical Deposition Correlations.
    Martin AR; Finlay WH
    J Aerosol Med Pulm Drug Deliv; 2022 Jun; 35(3):109-120. PubMed ID: 35699409
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.